SCHEMBL30103052

SCHEMBL30103052

COc1cccc(-c2ncc(Cn3ncc4cc(Cl)cc(C(=O)O)c43)cn2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.47
NR1H2 P55055 2/20 0.45
NR1H3 Q13133 2/20 0.45
CCR2 P41597 1/20 0.41
EGLN1 Q9GZT9 1/20 0.41
MET P08581 1/20 0.41
LMNA P02545 1/20 0.40
HSD17B10 Q99714 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
PPARG P37231 2/20 0.40
DHODH Q02127 1/20 0.40
HCAR3 P49019 1/20 0.40
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
SLC16A3 O15427 1/20 0.40
SLC16A1 P53985 1/20 0.40
MCTS1 Q9ULC4 1/20 0.40
WNK1 Q9H4A3 1/20 0.40
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24785096 1.00 KMT2A (0.47) KMT2ANR1H2NR1H3CCR2EGLN1
SCHEMBL24785074 0.92 NR1H2 (0.42) KMT2ANR1H2NR1H3METLMNA
SCHEMBL30103084 0.92 NR1H2 (0.42) KMT2ANR1H2NR1H3METLMNA
SCHEMBL30103058 0.90 NPBWR1 (0.41) KMT2ACCR2EGLN1
SCHEMBL24784545 0.90 NPBWR1 (0.41) KMT2ACCR2EGLN1
SCHEMBL24785451 0.87 MEN1 (0.43) KMT2ANR1H2NR1H3EGLN1LMNA
SCHEMBL30018739 0.87 MEN1 (0.43) KMT2ANR1H2NR1H3EGLN1LMNA
SCHEMBL24784619 0.86 P2RX7 (0.38) KMT2ANR1H2NR1H3METPPARG
SCHEMBL30103035 0.86 P2RX7 (0.38) KMT2ANR1H2NR1H3METPPARG
SCHEMBL24784641 0.85 MDM2 (0.36) KMT2AEGLN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115448913-A Bicyclic compounds for the treatment of EP2, EP4 receptor mediated diseases 武汉人福创新药物研发中心有限公司 2022-12-09 CN disclosed